Emergency Medicine Management of Opioid Use Disorder

What You Need to Know to Start Treatment Today (92444)

This training, developed by the Michigan Opioid Partnership and CA Bridge, focuses on the data supporting medication for opioid use disorder (MOUD), pharmacology, and the steps required to start someone on buprenorphine. Presenters Andy King, MD; Arianna Campbell, PA-C; and Nick Rademacher, MD will highlight how using buprenorphine to treat opioid use disorder is both safe and highly effective, and efforts to increase access to this highly effective therapy. By the end of the training, participants will be ready to apply for their X-waiver and provide buprenorphine on their next shift. All emergency department (ED) clinicians will find this module helpful as a review of MOUD pharmacology and the principles of ED-based treatment.

At the conclusion of this training, learners should be able to:
✓ Define opioid use disorder as a medical and public health emergency
✓ Explain that medications are the most effective treatment for opioid use disorder
✓ Recall the pharmacology of Buprenorphine, Methadone, & Naltrexone
✓ Apply the principles of precipitated withdrawal
✓ Demonstrate how to diagnose someone with opioid use disorder
✓ Summarize how to start someone on buprenorphine in the emergency department

Claim your CME Credit

 

Video length: 1 hour 43 minutes = 1.75 CME credits

Presenters: Andy King, MD; Arianna Campbell, PA-C; Nick Rademacher, MD

Review Date: May 19, 2022
Original Release Date: May 19, 2022
Termination Date: July 1, 2025

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Michigan State University and the Community Foundation for Southeast Michigan. Michigan State University is accredited by the ACCME to provide continuing medical education for physicians.

Michigan State University designates this Enduring Material activity for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Summary of Financial Disclosures: All planners, reviewers, faculty presenters have nothing to disclose.
Commercial Support Disclosure: No commercial support was provided for this CME activity

Questions? Feel free to contact

Marissa Natzke

Project Manager, Health Initiatives, Michigan Opioid Partnership